Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Effective suicide gene therapy for leukemia in a model of insertional oncogenesis in mice.

Effective suicide gene therapy for leukemia in a model of insertional oncogenesis in mice. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Effective suicide gene therapy for leukemia in a model of insertional oncogenesis in mice. Abstract Text:

    martina blumenthalMartina Blumenthal,dianne skeltonDianne Skelton,karen a pepperKaren A Pepper,thomas jahnThomas Jahn,emily methangkoolEmily Methangkool,donald b kohnDonald B Kohn,martina blumenthalMartina Blumenthal,dianne skeltonDianne Skelton,karen a pepperKaren A Pepper,thomas jahnThomas Jahn,emily methangkoolEmily Methangkool,donald b kohnDonald B Kohn,

    The safety of gene therapy using hematopoietic stem cells may be increased by including a suicide gene in the therapeutic vector to eliminate adverse events like insertional oncogenesis while retaining the clinical benefits. We have developed a model of experimental insertional oncogenesis by transducing the murine factor-dependent leukemia cell line Ba/F3 with a bicistronic Moloney murine leukemia virus retroviral vector encoding a murine oncogene (cKit(D814V)) in addition to one of three suicide genes: Herpes simplex virus thymidine kinase (HSV-TK); SR39, an HSV-TK mutant with an increased affinity for the drug substrate Ganciclovir (GCV); or sc39, a splice-corrected version of SR39. Following intravenous challenge with transduced Ba/F3 clones and treatment with GCV, leukemia developed in mice given cells expressing HSV-TK, but not SR39 or sc39. In vitro GCV resistance was observed in heterogeneously transduced Ba/F3 pools at 2.5-14%, and single-nucleotide changes or partial loss of the suicide gene were identified as mechanisms of drug escape. However, GCV treatment resulted in 80-100% survival of mice challenged even with pools of partially resistant Ba/F3 cells expressing SR39 or sc39. Thus, in this model of vector-driven insertional oncogenesis, a suicide gene approach was effective for eliminating leukemia using modified HSV-TK variants with improved biological activity.Molecular Therapy (2007) 15, 183-192. doi:10.1038/sj.mt.6300015.

    Effective suicide gene therapy for leukemia in a model of insertional oncogenesis in mice. Publishing Authors By Initials

    m blumenthalM Blumenthal,d skeltonD Skelton,ka pepperKA Pepper,t jahnT Jahn,e methangkoolE Methangkool,db kohnDB Kohn,m blumenthalM Blumenthal,d skeltonD Skelton,ka pepperKA Pepper,t jahnT Jahn,e methangkoolE Methangkool,db kohnDB Kohn,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Effective suicide gene therapy for leukemia in a model of insertional oncogenesis in mice. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Molecular therapy : the journal of the American So

    VOLUME: 15

    Page Numbers: 183-92

    Journal Abbreviation: Mol. Ther.

    ISSN: 1525-0016

    DAY: 13

    MONTH: Jan

    YEAR: 2007

    Effective suicide gene therapy for leukemia in a model of insertional oncogenesis in mice. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100890581

    Effective suicide gene therapy for leukemia in a model of insertional oncogenesis in mice. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Effective suicide gene therapy for leukemia in a model of insertional oncogenesis in mice. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Effective suicide gene therapy for leukemia in a model of insertional oncogenesis in mice.

    AFFILIATION: 1Department of Molecular Microbiology and Immunology, University of Southern California, Keck School of Medicine, University of Los Angeles, California, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Mol Ther

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Effective suicide gene therapy for leukemia in a model of insertional oncogenesis in mice Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News